Journal articles on the topic 'Monoamine'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Monoamine.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Zhou, Shi-Sheng, Yi-Ming Zhou, Da Li, and Qiang Ma. "Early Infant Exposure to Excess Multivitamin: A Risk Factor for Autism?" Autism Research and Treatment 2013 (2013): 1–8. http://dx.doi.org/10.1155/2013/963697.
Full textAksoz, Begum E., and Erkan Aksoz. "Vital Role of Monoamine Oxidases and Cholinesterases in Central Nervous System Drug Research: A Sharp Dissection of the Pathophysiology." Combinatorial Chemistry & High Throughput Screening 23, no. 9 (2020): 877–86. http://dx.doi.org/10.2174/1386207323666200220115154.
Full textAnlauf, Martin, Rolf Eissele, Martin K. H. Schäfer, et al. "Expression of the Two Isoforms of the Vesicular Monoamine Transporter (VMAT1 and VMAT2) in the Endocrine Pancreas and Pancreatic Endocrine Tumors." Journal of Histochemistry & Cytochemistry 51, no. 8 (2003): 1027–40. http://dx.doi.org/10.1177/002215540305100806.
Full textMurtazina, Alya R., Nadegda S. Bondarenko, Tatiana S. Pronina, et al. "A Comparative Analysis of CSF and the Blood Levels of Monoamines As Neurohormones in Rats during Ontogenesis." Acta Naturae 13, no. 4 (2021): 89–97. http://dx.doi.org/10.32607/actanaturae.11516.
Full textHollander, Eric. "Parkinson's Disease, Tourette Syndrome, and the Changing Nature of Depression: The Dog Days of Summer." CNS Spectrums 13, no. 8 (2008): 643–44. http://dx.doi.org/10.1017/s1092852900013729.
Full textBelmaker, Robert H. "The Future of Depression Psychopharmacology." CNS Spectrums 13, no. 8 (2008): 682–87. http://dx.doi.org/10.1017/s1092852900013766.
Full textMooslehner, Katrin A., Pok Man Chan, Weiming Xu, et al. "Mice with Very Low Expression of the Vesicular Monoamine Transporter 2 Gene Survive into Adulthood: Potential Mouse Model for Parkinsonism." Molecular and Cellular Biology 21, no. 16 (2001): 5321–31. http://dx.doi.org/10.1128/mcb.21.16.5321-5331.2001.
Full textCai, Lu, Chao Wang, Xiao-kui Huo, et al. "Effect of Alkaloids Isolated fromPhyllodium pulchellumon Monoamine Levels and Monoamine Oxidase Activity in Rat Brain." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/6826175.
Full textNilsson, G. E., A. A. Alfaro, and P. L. Lutz. "Changes in turtle brain neurotransmitters and related substances during anoxia." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 259, no. 2 (1990): R376—R384. http://dx.doi.org/10.1152/ajpregu.1990.259.2.r376.
Full textNishimura, Mitsuhiro, Kohji Sato, Tomoya Okada, et al. "Ketamine Inhibits Monoamine Transporters Expressed in Human Embryonic Kidney 293 Cells." Anesthesiology 88, no. 3 (1998): 768–74. http://dx.doi.org/10.1097/00000542-199803000-00029.
Full textSepp, Krisztián, Zsolt Molnár, Anna M. László, et al. "Study of the Potential Endocrine-Disrupting Effects of Phenylurea Compounds on Neurohypophysis Cells In Vitro." International Journal of Endocrinology 2019 (February 10, 2019): 1–9. http://dx.doi.org/10.1155/2019/1546131.
Full textHarvey, P. J., X. Li, Y. Li, and D. J. Bennett. "Endogenous Monoamine Receptor Activation Is Essential for Enabling Persistent Sodium Currents and Repetitive Firing in Rat Spinal Motoneurons." Journal of Neurophysiology 96, no. 3 (2006): 1171–86. http://dx.doi.org/10.1152/jn.00341.2006.
Full textBradner, Joshua M., Vrinda Kalia, Fion K. Lau, et al. "Genetic or Toxicant-Induced Disruption of Vesicular Monoamine Storage and Global Metabolic Profiling in Caenorhabditis elegans." Toxicological Sciences 180, no. 2 (2021): 313–24. http://dx.doi.org/10.1093/toxsci/kfab011.
Full textMartin-Iverson, Mathew T., and Bruce A. Lodge. "Effects of chronic treatment of rats with "designer" amphetamines on brain regional monoamines." Canadian Journal of Physiology and Pharmacology 69, no. 12 (1991): 1825–32. http://dx.doi.org/10.1139/y91-270.
Full textWallin, Anders, Kaj Blennow, Åke Edman, and Jan-Erik Månsson. "Decreased Lumbar Cerebrospinal Fluid Levels of Monoamine Metabolites in Vascular Dementia." International Psychogeriatrics 8, no. 3 (1996): 425–36. http://dx.doi.org/10.1017/s1041610296002785.
Full textD'Amico, Jessica M., Katherine C. Murray, Yaqing Li та ін. "Constitutively active 5-HT2/α1 receptors facilitate muscle spasms after human spinal cord injury". Journal of Neurophysiology 109, № 6 (2013): 1473–84. http://dx.doi.org/10.1152/jn.00821.2012.
Full textKrysenko, Sergii, and Wolfgang Wohlleben. "Polyamine and Ethanolamine Metabolism in Bacteria as an Important Component of Nitrogen Assimilation for Survival and Pathogenicity." Medical Sciences 10, no. 3 (2022): 40. http://dx.doi.org/10.3390/medsci10030040.
Full textBoyle, Natalie, Sarah Betts, and Hui Lu. "Monoaminergic Modulation of Learning and Cognitive Function in the Prefrontal Cortex." Brain Sciences 14, no. 9 (2024): 902. http://dx.doi.org/10.3390/brainsci14090902.
Full textHuang, Yu-Hong, Akio Ito, and Ryohachi Arai. "Immunohistochemical Localization of Monoamine Oxidase Type B in Pancreatic Islets of the Rat." Journal of Histochemistry & Cytochemistry 53, no. 9 (2005): 1149–58. http://dx.doi.org/10.1369/jhc.5a6658.2005.
Full textInyushin, M. Y., A. Huertas, Y. V. Kucheryavykh, et al. "L-DOPA Uptake in Astrocytic Endfeet Enwrapping Blood Vessels in Rat Brain." Parkinson's Disease 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/321406.
Full textKozlovskii, V. L., M. Yu Popov, D. N. Kosterin, and O. V. Lepik. "Heterogeneity of the mechanisms of action of antidepressants." V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY, no. 1 (April 12, 2021): 11–17. http://dx.doi.org/10.31363/2313-7053-2021-1-11-17.
Full textErnst, M. "Selegiline in ADHD Adults: Plasma Monoamines and Monoamine Metabolites." Neuropsychopharmacology 16, no. 4 (1997): 276–84. http://dx.doi.org/10.1016/s0893-133x(96)00243-6.
Full textFavoretto, Cristiane A., Yasmin C. Nunes, Giovana C. Macedo, Janaína Silva Rocha Lopes, and Isabel M. Hartmann Quadros. "Chronic social defeat stress: Impacts on ethanol-induced stimulation, corticosterone response, and brain monoamine levels." Journal of Psychopharmacology 34, no. 4 (2020): 412–19. http://dx.doi.org/10.1177/0269881119900983.
Full textAndriuskevicius, Tomas, Brenna Parke, Anna Rhodes, Leigh Knight, Parastoo Hashemi, and Claire A. Higgins. "P20 Characterizing monoamine signalling in human dermal fibroblasts and keratinocytes." British Journal of Dermatology 190, no. 6 (2024): e88-e88. http://dx.doi.org/10.1093/bjd/ljae105.042.
Full textQuarta, Davide, and Charles H. Large. "Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats." Journal of Psychopharmacology 25, no. 12 (2010): 1703–11. http://dx.doi.org/10.1177/0269881110385598.
Full textNoga, Brian R., Alberto Pinzon, Riza P. Mesigil, and Ian D. Hentall. "Steady-State Levels of Monoamines in the Rat Lumbar Spinal Cord: Spatial Mapping and the Effect of Acute Spinal Cord Injury." Journal of Neurophysiology 92, no. 1 (2004): 567–77. http://dx.doi.org/10.1152/jn.01035.2003.
Full textPopov, N. S., D. A. Gavrilenko, V. Yu Balabanyan, et al. "Quantitative determination of monoamine neurotransmitters in rat brain homogenates using HPLC-MS/MS." Pharmacokinetics and Pharmacodynamics, no. 4 (January 18, 2023): 33–42. http://dx.doi.org/10.37489/2587-7836-2022-4-33-42.
Full textRamesh, Muthusamy, and Arunachalam Muthuraman. "Quantitative Structure-Activity Relationship (QSAR) Studies for the Inhibition of MAOs." Combinatorial Chemistry & High Throughput Screening 23, no. 9 (2020): 887–97. http://dx.doi.org/10.2174/1386207323666200324173231.
Full textPetkov, V. D., S. L. Stancheva, V. V. Petkov, and L. G. Alova. "Age-related changes in brain biogenic monoamines and monoamine oxidase." General Pharmacology: The Vascular System 18, no. 4 (1987): 397–401. http://dx.doi.org/10.1016/0306-3623(87)90097-8.
Full textHamalainen, M., and J. Kohonen. "Studies on the effect of monoamine antagonists on the morphogenesis of the newt." International Journal of Developmental Biology 33, no. 1 (1989): 157–63. https://doi.org/10.1387/ijdb.2562047.
Full textRaffo, Anthony, Kolbe Hancock, Teresa Polito, et al. "Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine." Journal of Endocrinology 198, no. 1 (2008): 41–49. http://dx.doi.org/10.1677/joe-07-0632.
Full textWilliams, C. H., J. Lawson, and F. R. C. Backwell. "Oxidation of 3-amino-1-phenylprop-1-enes by monoamine oxidase and their use in a continuous assay of the enzyme." Biochemical Journal 256, no. 3 (1988): 911–15. http://dx.doi.org/10.1042/bj2560911.
Full textTaraskina, A. E., A. M. Zabotina, R. F. Nasyrova, et al. "The effect of antipsychotic drug on monoamine receptors in peripheral blood mononuclear cells: affinity linked mechanism." Biomeditsinskaya Khimiya 64, no. 2 (2018): 201–7. http://dx.doi.org/10.18097/pbmc20186402201.
Full textStahl, Stephen M. "Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity." CNS Spectrums 24, no. 5 (2019): 461–66. http://dx.doi.org/10.1017/s1092852919001470.
Full textLin, Yuh-Tzy, Wei-Shih Huang, Huei-Yann Tsai, Min-Min Lee, and Yuh-Fung Chen. "In vivo microdialysis and in vitro HPLC analysis of the impact of paeoniflorin on the monoamine levels and their metabolites in the rodent brain." BioMedicine 9, no. 2 (2019): 11. http://dx.doi.org/10.1051/bmdcn/2019090211.
Full textMAYES, LINDA C. "Developing brain and in utero cocaine exposure: Effects on neural ontogeny." Development and Psychopathology 11, no. 4 (1999): 685–714. http://dx.doi.org/10.1017/s0954579499002278.
Full textSchreiber, MD, JA Madden, RF Covert, MB Hershenson, and LJ Torgerson. "Concentration-dependent effects of cocaine on monoamine-induced constriction of cannulated, pressurized cerebral arteries from fetal sheep." Reproduction, Fertility and Development 7, no. 5 (1995): 1389. http://dx.doi.org/10.1071/rd9951389.
Full textGoldberg, Joel S., Clifton E. Bell, and David A. Pollard. "Revisiting the Monoamine Hypothesis of Depression: A New Perspective." Perspectives in Medicinal Chemistry 6 (January 2014): PMC.S11375. http://dx.doi.org/10.4137/pmc.s11375.
Full textBeaver, Jasmin N., Brady L. Weber, Matthew T. Ford, Anna E. Anello, Sarah K. Kassis, and T. Lee Gilman. "Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools." Cells 11, no. 12 (2022): 1874. http://dx.doi.org/10.3390/cells11121874.
Full textBenedetti, M. Strolin, P. Dosiert, and K. F. Tipton. "Developmental Aspects of the Monoamine-Degrading Enzyme Monoamine Oxidase." Developmental Pharmacology and Therapeutics 18, no. 3-4 (1992): 191–200. http://dx.doi.org/10.1159/000480622.
Full textFišar, Zdeněk. "Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase." Progress in Neuro-Psychopharmacology and Biological Psychiatry 38, no. 1 (2012): 68–77. http://dx.doi.org/10.1016/j.pnpbp.2011.12.010.
Full textStancheva, S. L., and L. G. Alova. "Adafenoxate: A monoamine oxidase and biogenic monoamine uptake inhibitor." Pharmacological Research 31 (January 1995): 128. http://dx.doi.org/10.1016/1043-6618(95)86771-6.
Full textRoy, Alec, David Pickar, Markku Linnoila, Allen R. Doran, Philip Ninan, and Steven M. Paul. "Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia." Psychiatry Research 15, no. 4 (1985): 281–92. http://dx.doi.org/10.1016/0165-1781(85)90065-4.
Full textHeninger, G., P. Delgado, and D. Charney. "The Revised Monoamine Theory of Depression: A Modulatory Role for Monoamines, Based on New Findings From Monoamine Depletion Experiments in Humans." Pharmacopsychiatry 29, no. 01 (1996): 2–11. http://dx.doi.org/10.1055/s-2007-979535.
Full textSacher, Julia, Eugenii A. Rabiner, Michael Clark, et al. "Dynamic, Adaptive Changes in MAO-A Binding after Alterations in Substrate Availability: An in vivo [11C]-Harmine Positron Emission Tomography Study." Journal of Cerebral Blood Flow & Metabolism 32, no. 3 (2011): 443–46. http://dx.doi.org/10.1038/jcbfm.2011.184.
Full textAbidi, S. M. A., and W. A. Nizami. "Monoamine oxidase in amphistomes and its role in worm motility." Journal of Helminthology 74, no. 4 (2000): 283–88. http://dx.doi.org/10.1017/s0022149x0000041x.
Full textAbidi, S. M. A., and W. A. Nizami. "Monoamine oxidase in amphistomes and its role in worm motility." Journal of Helminthology 74, no. 4 (2000): 283–88. http://dx.doi.org/10.1017/s0022149x00701039.
Full textQiu, Jingying, Chengjiang Li, Zhichun Dong, and Jing Wang. "Anti-diabetic effect of a monoamine oxidase inhibitor (tranylcypromine) in rats with poorly-controlled blood glucose levels: A potential and novel therapeutic option for diabetes." Tropical Journal of Pharmaceutical Research 19, no. 6 (2020): 1249–54. http://dx.doi.org/10.4314/tjpr.v19i6.20.
Full textDelogu, G. L., F. Pintus, L. Mayán, et al. "MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis, in vitro study, and docking calculations." MedChemComm 8, no. 9 (2017): 1788–96. http://dx.doi.org/10.1039/c7md00311k.
Full textJiang, Yao, Di Zou, Yumeng Li, et al. "Monoamine Neurotransmitters Control Basic Emotions and Affect Major Depressive Disorders." Pharmaceuticals 15, no. 10 (2022): 1203. http://dx.doi.org/10.3390/ph15101203.
Full text